Patent · US Active

Bicyclic compound as RIP-1 kinase inhibitor and application thereof

US12351587B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Wei Wei · Lo Wu, CN
Peng Li · New York, US
Haiying He · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	May 29, 2020
Grant date	Jul 8, 2025
Priority date	—
Expiry date	Jul 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound represented by formula (I), isomers or pharmaceutically acceptable salts thereof, and application thereof in the preparation of drugs for treating diseases related to RIP-1 (receptor interacting protein) kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.